Nass Valley Confirms its New CEO as President and Issues Incentive Stock Options – Canada NewsWire

This post was originally published on this site

Trading Symbols
CSE: NVG

Deutsche Borse, Frankfurt: 3NVN
Germany: WKN A1JVHM/

ISIN CA6315202029
nassvalleygateway.com

VANCOUVER, April 15, 2019 /CNW/ – Nass Valley Gateway Ltd. (the “Company” or “Nass Valley”), wishes to announce that at its Board of Directors (“BoD”) meeting held on April 10, 2019 the BoD has confirmed its new CEO, Mr. John Peter Affenita as President and CEO of the Company. The Company also established a Corporate Governance & Environment Committee consisting of three initial members which will be nominated and appointed during its next BoD meeting.

The Company is also pleased to announce that stock options have been granted to Directors, Officers, Committee Members and Consultants of the Company including its subsidiaries, to purchase up to an aggregate of 1,555,000 common shares of the Company. The stock options will be exercisable at a price of $0.18 per share with expiration date of April 10, 2022. 

About Nass Valley

Nass Valley Gateway (CSE: “NVG”; Frankfurt: “3NVN”) is a diversified healthcare company which is focused to further expand the business of its acquired subsidiary Pro-Thotics Technology Inc. (“PTI”) which was established in 1988. The Company is increasing its marketing of durable medical equipment products (DME-Business) on a national level, to encompass all states of the USA and other areas of North America and is aggressively developing the marketing, production and vertical integration of Cannabidiol (CBD) products without Tetrahydrocannabinol (“THC”) content for internal use including CBD infused skin, bath, and body care products of its wholly owned subsidiary Advanced Bioceuticals Limited (“ABL”).

PTI is licensed to supply its products also to Medicare patients in the US and has established, over its more than 25 -year history, a database of more than 200,000 patients, located throughout the U.S. and Puerto Rico, who were seeking wellness from pain relief.

Through its subsidiary ABL, Nass Valley is determined to expand upon this pain relief concept tof its ABL-Business and to aggressively focus on the hemp based CBD marketplace with a global market of $3.1 billion (New Frontier Data) and expand its current New Jersey operations internationally.

We seek Safe Harbor.

Neither the CSE nor its Regulation Services Provider has reviewed or accepts responsibility for the adequacy or accuracy of the contents of this news release.

SOURCE Nass Valley Gateway Ltd.

For further information: John Affenita, President & CEO, Phone: 1.604-617-6794

Related Links

http://nvg.nassvalleygateway.com

Leave a Reply